Newsroom
Sorted by: Latest
-
UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
MONTPELLIER, France--(BUSINESS WIRE)--Medincell (Euronext Paris: MEDCL) partner, Teva Pharmaceuticals (NYSE and TASE: TEVA), announced today that UZEDY® U.S. net sales reached a record $77 million in Q2 2026, up 43% year-on-year. Teva raised its 2026 UZEDY® revenue outlook to $270 million–$290 million, from $250 million–$280 million previously. According to Teva, based on IQVIA1 data, UZEDY® continues to be the fastest-growing long-acting injectable treatment for schizophrenia in the U.S. U.S....
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
flyExclusive Deepens Vertical Integration With Expanded Maintenance and New Pilot Training Center at the Global TransPark, Backed by $30 Million North Carolina Investment
KINSTON, N.C.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSE American: FLYX), one of the largest private jet operators in North America — and the only fully integrated one — today announced that it has secured a $30 million grant from the State of North Carolina to expand its maintenance and repair operation and develop a new pilot training facility at the North Carolina Global TransPark in Kinston. The investment is expected to create more than one hundred new aviation jobs in Lenoir County and fur...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Fortive Reports Second Quarter 2026 Results
EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) today announced financial results for the second quarter of 2026. “Q2 marked another quarter of strong financial performance and execution by our team. Core revenue growth accelerated to 6.7%, adjusted EBITDA grew 12%, and adjusted EPS growth was 28% in the quarter. In addition to accelerating profitable growth, we continued to deliver on our commitment to disciplined capital allocation by completing an additional ~$20...
-
Monro, Inc. Announces First Quarter Fiscal 2027 Financial Results
FAIRPORT, N.Y.--(BUSINESS WIRE)--Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive repair and tire services, today announced financial results for its first quarter ended June 27, 2026. First Quarter Results Sales for the first quarter of the fiscal year ending March 27, 2027 (“fiscal 2027”) decreased 4.6% to $287.1 million, as compared to sales of $301.0 million for the first quarter of the fiscal year ended March 28, 2026 (“fiscal 2026”). This was primarily driven by a reduction in...
-
Owens Corning Appoints Jonathan Collins as Chief Financial Officer to Advance Strategic Priorities and Strengthen Value Creation
TOLEDO, Ohio--(BUSINESS WIRE)--Owens Corning (NYSE: OC), a branded building products leader, today announced that Jonathan Collins has been named Executive Vice President and Chief Financial Officer, effective August 10. Collins is a seasoned finance executive with strong operational expertise and a proven background in scaling rapidly evolving businesses and driving growth. Collins succeeds Todd Fister, who assumes the role of President and Chief Operating Officer, following a planned transiti...
-
Aramark Correctional Services Reimagines Dining with Beyond the Tray, a First-of-Its-Kind Hospitality Program
PHILADELPHIA--(BUSINESS WIRE)--Aramark Correctional Services (ACS) announced today that it will launch Beyond the Tray with pilots in the Ohio and Indiana Departments of Correction this summer. The hospitality-driven dining program reimagines correctional dining, prioritizing dignity, consistency, and daily engagement. "Without compromising safety, we challenged ourselves to remove long-standing assumptions about correctional dining and build something better," said Tim Barttrum, President and...